#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

NewLink Genetics appoints Eugene P. Kennedy as CMO

Share on Twitter Share on LinkedIn
Staff Writer | Austin, Tx., USA | November 16, 2017
NewLink GeneticsNovember 16, 2017, Austin, Tx., USA - NewLink Genetics Corporation, a biopharmaceutical company, announced the appointment of Eugene P. Kennedy to the role of chief medical officer.
Dr. Kennedy’s previous role at NewLink Genetics was Vice President of Clinical and Medical Affairs.

Dr. Kennedy joined NewLink in 2014 from Thomas Jefferson University in Philadelphia, PA where he served as Associate Professor of Surgery and held leadership positions as Chief of the Section of Pancreaticobiliary Surgery and Co-Director of the Jefferson Pancreas, Biliary, and Related Cancers Center.

Previously, he has held faculty positions at the Johns Hopkins Hospital in Baltimore, MD and the Louisiana State University School of Medicine in New Orleans, LA.

Dr. Kennedy obtained his undergraduate education at the University of Virginia and received his medical degree from the Medical College of Virginia.

He completed a residency and fellowship in Surgery and Surgical Oncology as well as a research fellowship in tumor immunology at the Johns Hopkins Hospital.